Suppr超能文献

CpG 位点的选择性甲基化在调节结合位点控制肾母细胞瘤中 NNAT 的表达。

Selective methylation of CpGs at regulatory binding sites controls NNAT expression in Wilms tumors.

机构信息

Department of Pediatric Surgery, Research Laboratories, Ludwig-Maximilians-University, Munich, Germany.

出版信息

PLoS One. 2013 Jun 25;8(6):e67605. doi: 10.1371/journal.pone.0067605. Print 2013.

Abstract

Aberrant expression of imprinted genes, such as those coding for the insulin-like growth factor 2 (IGF2) and neuronatin (NNAT), is a characteristic of a variety of embryonic neoplasms, including Wilms tumor (WT). In case of IGF2, it is generally accepted that loss of imprinting in a differentially methylated region of the IGF2/H19 locus results in biallelic expression and, thus, upregulation of the gene. In this study we examined methylation pattern at potential regulatory elements of the paternally expressed NNAT gene in a cohort of WT patients in order to further characterize the molecular mechanism causing overexpression of this regulatory gene. We demonstrate that transcriptional upregulation of NNAT in WT is grossly independent of the bladder cancer-associated protein (BLCAP) gene, an imprinted gene within the imprinted domain of the NNAT locus. However, expression of the BLCAP transcript isoform v2a formerly known to be selectively expressed from the paternal allele in brain was associated with high expression of NNAT. This contrasts the situation we found at the IGF2/H19 locus, which shows high overexpression of IGF2 and inversely correlated expression of the H19 gene in WT. An analysis of DNA methylation in two potential regulatory regions of the NNAT locus by pyrosequencing revealed significant hypomethylation of the tumors compared to normal kidney tissue. Interestingly, the difference in DNA methylation was highest at CpGs that were observed within three putative binding sites of the CCCTC-binding factor CTCF. Most importantly, hypomethylation of both NNAT regulatory regions is significantly associated with the upregulation of NNAT expression and the BLCAP_v2a transcript. Our data indicate that the methylation status of a not-yet-described regulatory element within the NNAT locus that contains four potential CTCF binding sites determines the expression level of NNAT and the nearby located BLCAP_v2a transcript, thereby suggesting a functional role in the aberrant upregulation of NNAT in WT.

摘要

印迹基因的异常表达,如胰岛素样生长因子 2(IGF2)和神经元特有的八聚体结合蛋白(NNAT)等,是多种胚胎肿瘤的特征,包括肾母细胞瘤(WT)。就 IGF2 而言,通常认为 IGF2/H19 基因座差异甲基化区域的印迹丢失导致等位基因的双等位基因表达,从而导致基因的上调。在这项研究中,我们检查了 WT 患者队列中潜在调节元件的甲基化模式,以便进一步表征导致该调节基因过度表达的分子机制。我们证明,WT 中 NNAT 的转录上调与膀胱癌相关蛋白(BLCAP)基因无关,BLCAP 基因是 NNAT 基因座印迹域内的一个印迹基因。然而,以前在大脑中从父本等位基因选择性表达的 BLCAP 转录本异构体 v2a 的表达与 NNAT 的高表达相关。这与我们在 IGF2/H19 基因座中发现的情况形成对比,IGF2 的高过表达与 WT 中 H19 基因的表达呈负相关。对 NNAT 基因座两个潜在调节区的 DNA 甲基化进行 pyrosequencing 分析表明,与正常肾组织相比,肿瘤的甲基化程度显著降低。有趣的是,在三个推定的 CCCTC 结合因子 CTCF 结合位点内观察到的 CpG 差异最大。最重要的是,NNAT 两个调节区的低甲基化与 NNAT 表达和附近的 BLCAP_v2a 转录物的上调显著相关。我们的数据表明,NNAT 基因座内一个尚未描述的调节元件的甲基化状态决定了 NNAT 的表达水平和附近的 BLCAP_v2a 转录物,从而提示在 WT 中 NNAT 的异常上调中具有功能作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d15/3692448/ee1dc8317fe8/pone.0067605.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验